// App-Quantinova.ai

845 : Patients’ Reported Perceptions on Satisfaction with Immune Thrombocytopenia Treatments: Results from the ITP World Impact Survey (I-WISh)

Researchers

Presenter

  • Waleed Ghanima

Principal Investigators

  • James B. Bussel

  • Drew Provan

  • Alexandra Kruse

  • Caroline Kruse

  • Yoshiaki Tomiyama

  • Ming Hou

  • Cristina Santoro

  • Serge Laborde

  • Mervyn Morgan

  • Barbara Lovrencic

  • Tom Bailey

  • Jens Haenig

  • Nichola Cooper

Medical Centers

  • Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway

  • Division of Hematology & Medical Oncology, Weill Cornell Medical College, New York, NY

  • Barts and the London School of Medicine, London, United Kingdom

  • Platelet Disorder Support Association,Cleveland,Vereinigte Staaten

  • Osaka University Hospital, Suita, Japan

  • Department of Breast Surgery, Qilu Hospital, Shandong University, Jinan, China

  • Hematology, University Hospital Policlinico Umberto I, Rome, Rome, Lazio, Italy

  • O’Cyto, Saint Loubès, France

  • ITP Support Association,Bedfordshire,United Kingdom

  • Italian Association Immune Thrombocytopenic Purpura,Caprino Veronese,Italy

  • Adelphi Real World, Bollington, United Kingdom

  • Novartis AG, Basel, Switzerland

  • Hammersmith Hospital, Imperial College, London, United Kingdom

Locations

  • Norway

  • United States

  • United Kingdom

  • Japan

  • China

  • Italy

  • France

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved